期刊文献+

载顺铂磁性纳米药物在小鼠体内的组织分布 被引量:3

Tissue Distribution of Cisplatin-Loaded Magnetic Nanomedicine in Mice
原文传递
导出
摘要 目的研究海藻酸钠改性载顺铂磁性纳米药物的组织分布特征。方法昆明小鼠84只,随机分为实验组和对照组,分别按顺铂剂量10 mg.kg-1从尾静脉推注载顺铂磁性纳米药物或顺铂0.2 mL,于给药后1,2,4,10 h,1,3,7 d,分7个时间点各处死实验组和对照组一组小鼠(6只),取出小鼠的心、肝、脾、肺、肾组织,经强酸湿法消化后在原子吸收光谱仪上测定各组织样本中铂的浓度。结果给药后7个不同时间点磁性顺铂在各组织中的浓度均明显高于顺铂(P<0.001),7 d后实验组中肝、脾、肾组织中磁性顺铂的浓度分别为(8.31±1.92)、(24.23±6.02)、(3.02±0.74)μg.g-1,而对照组中顺铂分别只有(1.47±0.64)、0、(1.62±0.38)μg.g-1。结论一次性给药后海藻酸钠改性载顺铂磁性纳米药物在小鼠体内的分布与顺铂不同,前者主要分布于肝、脾,并在组织中维持较长时间,后者主要分布于肝、肾,较快从组织中被清除。 OBJECTIVE To investigate the tissues distribution of sodium alginate modified Cis-Dichlorodiammine platinum-loaded magnetic nanoparticle(CDDP-MNP).METHODS 84 Kunming mice were divided into experimental group and control group randomly.Each group was divided into 7 subgroups again and 6 mice in each subgroup.The same dose(0.2 mL,corresponding cis-platin 10 mg·kg-1) of CDDP-MNP and CDDP were administered by tail vein of mice.Six mice were killed in experimental group and control group respectively after administration for 1,2,4,10 h,1,3 and 7 d,and then the heart,liver,spleen,lung and kidney was picked out from mice and digested by nitric acid.Finally,the concentration of platinum in these tissues was detected using graphite furnace atomic absorption spectrum analysis.RESULTS The concentrations of CDDP-MNP were all significantly higher than that of CDDP in different tissues at seven different time points after administration.After administration for 7 d,the concentrations of CDDP-MNP in livers,spleens and kidneys in the experimental group were(8.310±1.92),(24.23±6.02) and(3.02±0.74)μg·g-1 respectively,and that of CDDP in the control group were only(1.47±0.64),0,(1.62±0.38)μg·g-1.CONCLUSION After an administration,the distribution of sodium alginate modified Cis-Dichlorodiammine platinum-loaded magnetic nanoparticles in mouse was different from those of cisplatin.The former were mainly distributed in liver and spleen and stayed longer in tissues,and the latter were mainly distributed in liver and kidney and fast eliminated from tissues.
出处 《中国药学杂志》 CAS CSCD 北大核心 2010年第21期1644-1647,共4页 Chinese Pharmaceutical Journal
基金 广州市科技计划项目(2004Z3-D2-91) 广东省自然科学基金重点项目(36645) 广东省科技计划项目(2006B35802002 2009B080701038) 国家自然科学基金项目(30672297)联合资助
关键词 磁性纳米药物 顺铂 原子吸收光谱 组织 分布 magnetic nanomedicine cisplatin atomic absorption tissue distribution
  • 相关文献

参考文献10

  • 1SCARPACE S L,BRODZIKF A,MEHDI S,et al.Treatment ofhead and neck cancers:issues for clinical pharmacists[].Phar-macotherapy.2009
  • 2TSANG R Y,AL-FAYEAT,AUHJ.Cisplatin overdose:toxic-ities and management[].Drug Safety.2009
  • 3VERMORKEN J B,REMENAR E,VAN HERPEN C,et al.Cisplatin,fluorouracil,and docetaxel in unresectable head andneck cancer[].Netherlands Journal of Medicine.2007
  • 4BOULIKAS T.Clinical overviewon lipoplatin:a successful lipo-somal formulation of cisplatin[].Expert Opinion on Investigational Drugs.2009
  • 5TRIPATHY T,PANDEY S R,KARMAKAR N C,et al.Novelflocculating agent based on sodium alginate and acrylamide[].Euro Polymer J.1999
  • 6XU X Q,SHEN H,XU J R,et al.The colloidal stability andcore-shell structure of magnetic nanoparticles coated with alginate[].Applied Surface Science.2006
  • 7ALEXIOUC,JURGONS R,SCHMID R,et al.In vitroandinvivoinvestigations of targeted chemotherapy with magnetic nanop-articles[].JMagn Magn Mater.2005
  • 8MUSS HB,BERRY D A,CIRRINCIONE C Tet al.Adjuvant chemotherapy in older women with early-stage breast cancer[].The New England Journal of Medicine.2009
  • 9Matsumura Y.Poly (amino acid) micelle nanocarriers in preclinical and clinical studies[].Advanced Drug Delivery Reviews.2008
  • 10Moghimi SM,Hunter AC,Murray JC.Nanomedicine: current status and future prospects[].FASEB JournalThe.2005

同被引文献50

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部